Related Experiment Videos
Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversity
O Neyrolles1, I Chambaud, S Ferris
1Unité d'Oncologie Virale, Institut Pasteur, 75724 Paris Cedex 15, France.
Abstract:
Mycoplasma penetrans is a recently identified mycoplasma, isolated from urine samples collected from human immunodeficiency virus (HIV)-infected patients. Its presence is significantly associated with HIV infection. The major antigen recognized during natural and experimental infections is an abundant P35 lipoprotein which, upon extraction, segregates in the Triton X-114 detergent phase and is the basis of M. penetrans-specific serological assays. We report here that the P35 antigen undergoes spontaneous and reversible phase variation at high frequency, leading to heterogeneous populations of mycoplasmas, even when derived from a clonal lineage. This variation was found to be determined at the transcription level, and although this property is not unique among the members of the class Mollicutes, the mechanism by which it occurs in M. penetrans differs from those previously described for other Mycoplasma species. Indeed, the P35 phase variation was due neither to a p35 gene rearrangement nor to point mutations within the gene itself or its promoter. The P35 phase variation in the different variants obtained was concomitant with modifications in the pattern of other expressed lipoproteins, probably due to regulated expression of selected members of a gene family which was found to potentially encode similar lipoproteins. M. penetrans variants could be selected on the basis of their lack of colony immunoreactivity with a polyclonal antiserum against a Triton X-114 extract, strongly suggesting that the mechanisms involved in altering surface antigen expression might allow evasion of the humoral immune response of the infected host.
Insights
Mycoplasma penetrans, found in HIV-infected patients, exhibits P35 antigen phase variation. This immune evasion mechanism involves changes in surface lipoprotein expression, differing from other Mycoplasma species.
Area of Science:
- Microbiology
- Immunology
- Virology
Background:
- Mycoplasma penetrans is a recently identified bacterium associated with HIV infection.
- A key antigen, P35 lipoprotein, is crucial for Mycoplasma penetrans serological assays.
- This bacterium is isolated from urine samples of human immunodeficiency virus (HIV)-infected individuals.
Purpose of the Study:
- To investigate the phenomenon of P35 antigen phase variation in Mycoplasma penetrans.
- To elucidate the underlying mechanism of this variation and its implications for immune evasion.
Main Methods:
- Analysis of P35 antigen expression and its correlation with colony immunoreactivity.
- Investigation of gene transcription levels to understand variation at the molecular level.
- Characterization of the P35 gene and its promoter for mutations or rearrangements.
Main Results:
- Mycoplasma penetrans P35 antigen exhibits high-frequency spontaneous and reversible phase variation.
- This variation is regulated at the transcriptional level and is not due to gene rearrangement or point mutations.
- Phase variation is linked to altered expression of other lipoproteins, suggesting a coordinated gene family regulation.
Conclusions:
- The P35 phase variation mechanism in Mycoplasma penetrans is distinct from other Mycoplasma species.
- Altered surface antigen expression likely facilitates immune evasion in HIV-infected hosts.
- Understanding this variation is critical for developing effective diagnostics and therapeutics for Mycoplasma penetrans infections.